WCG’s Chief Medical Officer, Lindsay McNair, MD, MPH, MSBioethics, is interviewed by PharmaVOICE to discuss perspectives on recombinant DNA and mobile health.

Publication: PharmaVOICE
To read this article, please click here.

 

Print Friendly